Metraipolis › archive › dc_d606734aa805
Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes — Europe PMC PMID:41403449
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41403449
- DOI
- 10.3389/fphar.2025.1715585
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T03:23:03.937Z
- SHA-256 of the archived text
c5ba234336598f3f017c4d3c8397f2f8ff819d8f59df344cdfb7a588d6f9c7ac- Stable URL of this page
https://metraipolis.com/documento/dc_d606734aa805
How to cite
Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes — Europe PMC PMID:41403449 — Europe PMC (en), https://europepmc.org/article/MED/41403449 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d606734aa805 (Metraipolis archive dc_d606734aa805, sha256 c5ba234336598f3f017c4d3c8397f2f8ff819d8f59df344cdfb7a588d6f9c7ac)
BibTeX
@misc{dcd606734aa805,
title = {Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes — Europe PMC PMID:41403449},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41403449},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d606734aa805; sha256 c5ba234336598f3f017c4d3c8397f2f8ff819d8f59df344cdfb7a588d6f9c7ac},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41403449. Agents can read the archived copy with the MCP tool read_document.